Atossa Therapeutics, Inc.

US$2.12As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ATOSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (39.59%)
Div yield —
ROE (89.23%)
Biotechnology
Beta (5Y) 1.37
PE TTM —
TSR TTM (84.11%)
Mkt cap US$21.16M
ROIC (58.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.46
16.08%
(84.15%)
Hold 10|0|7|10|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.04
0.04
0.04
17.83%
26.11%
35.23%
37.41%
Revenue$M
1.548
1.532
1.570
1.531
9.07%
4.30%
5.09%
(0.28%)
Peers (US$21.16M)
Cap (US$)
PE
21.48M
—
20.68M
—
21.26M
—
Capital
TTM
5Y
10Y
Leveragex
0.741
0.331
0.255
EBIT/Intx
1.319
0.110
0.112
Own earn%
33.00
48.28
43.75
Sh yield%
30.61
35.31
33.96
Owners
Insiders/Inst%
14.43
31.45
Short interest%
0.61
SBC / revenue%
0.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
13–20
$1 testx
—
Incr. ROIC%
5